Biocryst Pharmaceuticals Inc
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
BCRX chart
What traders are saying about $BCRX
Latest postsBiocryst Pharmaceuticals Inc news
- Weekly Recap: Q3 growth and guidance increase and navenibart progress
TradingView ·
- Results: BioCryst Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates
Simply Wall St ·
- BioCryst Pharmaceuticals (BCRX) Raised Its Outlook, Is It Still Below Fair Value?
Yahoo Finance ·
- Biocryst Pharmaceuticals Stock Price Forecast. Should You Buy BCRX?
StockInvest.us ·
- BioCryst Pharmaceuticals, Inc. (BCRX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- BioCryst Pharmaceuticals, Inc. 2026 Q3 - Results - Earnings Call Presentation (NASDAQ:BCRX) 2026-11-06
Seeking Alpha ·
- Raised Outlook And Strong Quarter Could Change The Case For BioCryst Stock
Simply Wall St ·
- Wedbush Maintains BioCryst Pharmaceuticals(BCRX.US) With Buy Rating, Cuts Target Price to $17
Moomoo ·
- Biocryst Pharmaceuticals Inc. (BCRX) Earnings, Actual EPS, EPS Estimates & Results
Stocktwits ·
- BioCryst Pharmaceuticals Inc (BCRX) (Q3 2026) Earnings Call Highlights: ORLADEYO Revenue Climbs ...
Yahoo Finance ·
- BioCryst Pharmaceuticals (BCRX) Reports Strong Q3 2026 Revenue w
GuruFocus ·
- BioCryst to Present at Upcoming Investor Conferences
Yahoo Finance ·
Biocryst Pharmaceuticals Inc key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | $263.9M | -$88.9M | -$226.5M | -$247.1M |
| Diluted EPS | $1.21 | $-0.43 | $-1.18 | $-1.33 |
| Total assets (year end) | $514.2M | $490.4M | $517.0M | $550.0M |
| Cash and equivalents (year end) | $89.7M | $104.7M | $110.6M | $304.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Biocryst Pharmaceuticals Inc
- Ticker
- BCRX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 882796
Frequently asked questions
What exchange is Biocryst Pharmaceuticals Inc listed on?
Biocryst Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol BCRX.
What industry is Biocryst Pharmaceuticals Inc in?
Biocryst Pharmaceuticals Inc is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Biocryst Pharmaceuticals Inc headquartered?
Biocryst Pharmaceuticals Inc's business address on file with the SEC is in Durham, NC.
When does Biocryst Pharmaceuticals Inc's fiscal year end?
Biocryst Pharmaceuticals Inc's fiscal year ends on December 31.
How much revenue did Biocryst Pharmaceuticals Inc report?
Biocryst Pharmaceuticals Inc reported $25.2M in revenue for calendar year 2017, according to its SEC filings.